A carregar...
Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies
Treatment with the angiogenesis inhibitors bevacizumab, sunitinib, and sorafenib as single agents or in combination with conventional chemotherapy is becoming a cornerstone of modern anticancer therapy. However, the potential toxicity of these drugs, mainly to the cardiovascular system, is still bei...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228010/ https://ncbi.nlm.nih.gov/pubmed/20547589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0235 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|